CVS, a partner in the US’ federal program to vaccinate residents and staff of long-term care facilities, says it has completed the first round doses in all participating skilled nursing facilities as of Monday. The company has administered 1,039,365 doses in 7,822 skilled nursing facilities.
As part of the federal partnership program, CVS and Walgreens are contracted to administer Covid-19 vaccines to more than 40,000 long-term care facilities, including skilled nursing facilities, assisted living and other facilities. CVS anticipates completing administration of first round doses in all long-term care facilities by mid-February.
“We’ve administered nearly two million shots to one of our most vulnerable populations through onsite and, in many cases, room-to-room visits,” Karen Lynch, executive vice president of CVS Health, said in a press release.
Walgreens and CVS have come under fire for a slow rollout, with some nursing homes saying it has taken too long to get the shots. The company says that doses administered out of doses allocated is not an accurate way to its track progress; dose allocations were based on long-term care facility bed counts and multiplied by two to account for staff, “but at most facilities occupancy is far less than bed count and staff uptake remains low.”
Walgreens said last week it expected to complete administering nearly all of its first Covid-19 vaccine doses to nursing home residents and staff on Monday.
In its news release on Monday, CVS said that a Covid-19 vaccine will eventually be available to the public at its pharmacies based on vaccine availability and prioritization recommendations, and it has the capacity to administer 20 to 25 million shots per month. Currently, CVS pharmacies in Indiana, Massachusetts and New York are offering vaccines to specific age groups.